Status
Conditions
About
The purpose of this study is to compare abdominal weight gain and fat distribution to changes in brain morphology in people taking antipsychotic medications.
Full description
Abdominal weight gain is a significant side effect of antipsychotic medications. It has even been suggested to be part of the pathology of severe mental illnesses. Studies have shown that in persons with bipolar disorder, increased body mass index (BMI) is associated with irregular changes in the brain. This association has not been tested in persons with psychosis. In this study, we will be measuring abdominal fat distribution as measured by MRI to see if this is associated with abnormal brain morphology.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• None, other than those listed above
Loading...
Central trial contact
Heidi N Boyda, Ph.D.; Delrae Fawcett, M.Sc.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal